Minoru Ono

ECI, Inc. engages in the business of innovative drug discovery and its related services. It operates through the following segments: Drug Discovery Business, Drug Discovery Tool Supply and Health Food. The Drug Discovery Business segment engages in the research and development of drug discovery seeds and core technology. The Drug Discovery Tool Supply segment develops and sells laboratory equipment. The Health Food segment sells health food ingredients and agricultural supplements in bulk. The company was founded by Shiro Kanegasaki in June 1999 and is headquartered in Tachikawa, Japan.

MediBIC Group is a holding company which engages in the biotechnology industry that specializes in pharmacogenomics (PGx). It engages in analysis and reporting service on healthcare and drug development; information processing, services and consulting in biotech field; computer system design and development; drug & diagnostic product development; and business consulting services. The firm’s services also include sample banking and management service, GLP-compliant Gene Profiling Service, genetic testing service, licensing, cell culture systems and consumable sale. The company was founded on February 17, 2000 and is headquartered in Tokyo, Japan.

Part of MediBIC Group, MediBIC KK develops genomic medicines. The company is based in Tokyo, Japan. The Japanese company was founded by Yasuhiro Hashimoto.